EB
Epicrispr Biotechnologies, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$176.8Msold at filing
Total offering$212.8M$36M still open
Investors in the raise47count reported to the SEC
FiledAug 26, 2026first sale May 4, 2018
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lei QiDirector
Eric CrombezDirector
Anran LiDirector
Haorui ZhangExecutive Officer, Director
Jennifer KingDirector
Andrew LamDirector
Amber SalzmanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.